NCT01182077

A Study to Assess Drug Interaction of ASP015K and Midazolam

A Phase 1, Open Label, Crossover, Drug Interaction Study of the Pharmacokinetics of ASP015K and Midazolam After Separate and Concomitant Administration to Healthy Adult Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 30 (actual)
• Sponsor: Astellas Pharma Inc · Industry
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

The objective of the study is to characterize the effect of multiple doses of ASP015K on the pharmacokinetics of a single dose of midazolam.

Conditions

• Healthy
• Pharmacokinetics of ASP015K and Midazolam

Interventions

Type	Name	Description
DRUG	ASP015K	Oral
DRUG	Midazolam	Oral

Timeline

• Start date: 2010-06-01
• Primary completion: 2010-07-01
• Completion: 2010-07-01
• First posted: 2010-08-16
• Last updated: 2010-08-16

Locations

1 site across 1 country: United States